Cargando…
Health‐related quality of life around the time of diagnosis in patients with bladder cancer
OBJECTIVES: To quantify the health‐related quality of life (HRQoL) of patients with bladder cancer around the time of diagnosis and to test the hypotheses of a two‐factor model for the HRQoL questionnaire QLQ‐C30. METHODS: From participants in the Bladder Cancer Prognoses Programme, a multicentre co...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907410/ https://www.ncbi.nlm.nih.gov/pubmed/31077532 http://dx.doi.org/10.1111/bju.14804 |
_version_ | 1783478533127929856 |
---|---|
author | Yu, Evan Yi‐Wen Nekeman, Duncan Billingham, Lucinda J. James, Nicholas D. Cheng, KK Bryan, Richard T. Wesselius, Anke Zeegers, Maurice P. |
author_facet | Yu, Evan Yi‐Wen Nekeman, Duncan Billingham, Lucinda J. James, Nicholas D. Cheng, KK Bryan, Richard T. Wesselius, Anke Zeegers, Maurice P. |
author_sort | Yu, Evan Yi‐Wen |
collection | PubMed |
description | OBJECTIVES: To quantify the health‐related quality of life (HRQoL) of patients with bladder cancer around the time of diagnosis and to test the hypotheses of a two‐factor model for the HRQoL questionnaire QLQ‐C30. METHODS: From participants in the Bladder Cancer Prognoses Programme, a multicentre cohort study, sociodemographic data were collected using semi‐structured face‐to‐face interviews. Answers to the QLQ‐C30 were transformed into a scale from 0 to 100. HRQoL data were analysed in multivariate analyses. The hypothesized two‐factor (Physical and Mental Health) domain structure of the QLQ‐C30 was also tested with confirmatory factor analyses (CFA). RESULTS: A total of 1160 participants (78%) completed the questionnaire after initial visual diagnosis and before pathological confirmation. Despite non‐muscle‐invasive bladder cancer (NMIBC) being associated with a higher HRQoL than carcinoma invading bladder muscle, only the domain Role Functioning was clinically significantly better in patients with NMIBC. Age, gender, bladder cancer stage and comorbidity all had a significant influence on QLQ‐C30 scores. The CFA showed an overall good fit of the hypothesized two‐factor model. CONCLUSION: This study identified a baseline reference value for HRQoL for patients with bladder cancer, which allows better evaluation of any changes in HRQoL as disease progresses or after treatment. In addition, a two‐factor (Physical and Mental Health) model was developed for the QLQ‐C30. |
format | Online Article Text |
id | pubmed-6907410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69074102019-12-23 Health‐related quality of life around the time of diagnosis in patients with bladder cancer Yu, Evan Yi‐Wen Nekeman, Duncan Billingham, Lucinda J. James, Nicholas D. Cheng, KK Bryan, Richard T. Wesselius, Anke Zeegers, Maurice P. BJU Int Urological Oncology OBJECTIVES: To quantify the health‐related quality of life (HRQoL) of patients with bladder cancer around the time of diagnosis and to test the hypotheses of a two‐factor model for the HRQoL questionnaire QLQ‐C30. METHODS: From participants in the Bladder Cancer Prognoses Programme, a multicentre cohort study, sociodemographic data were collected using semi‐structured face‐to‐face interviews. Answers to the QLQ‐C30 were transformed into a scale from 0 to 100. HRQoL data were analysed in multivariate analyses. The hypothesized two‐factor (Physical and Mental Health) domain structure of the QLQ‐C30 was also tested with confirmatory factor analyses (CFA). RESULTS: A total of 1160 participants (78%) completed the questionnaire after initial visual diagnosis and before pathological confirmation. Despite non‐muscle‐invasive bladder cancer (NMIBC) being associated with a higher HRQoL than carcinoma invading bladder muscle, only the domain Role Functioning was clinically significantly better in patients with NMIBC. Age, gender, bladder cancer stage and comorbidity all had a significant influence on QLQ‐C30 scores. The CFA showed an overall good fit of the hypothesized two‐factor model. CONCLUSION: This study identified a baseline reference value for HRQoL for patients with bladder cancer, which allows better evaluation of any changes in HRQoL as disease progresses or after treatment. In addition, a two‐factor (Physical and Mental Health) model was developed for the QLQ‐C30. John Wiley and Sons Inc. 2019-06-07 2019-12 /pmc/articles/PMC6907410/ /pubmed/31077532 http://dx.doi.org/10.1111/bju.14804 Text en © 2019 The Authors BJU International Published by John Wiley & Sons Ltd on behalf of BJU International This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Urological Oncology Yu, Evan Yi‐Wen Nekeman, Duncan Billingham, Lucinda J. James, Nicholas D. Cheng, KK Bryan, Richard T. Wesselius, Anke Zeegers, Maurice P. Health‐related quality of life around the time of diagnosis in patients with bladder cancer |
title | Health‐related quality of life around the time of diagnosis in patients with bladder cancer |
title_full | Health‐related quality of life around the time of diagnosis in patients with bladder cancer |
title_fullStr | Health‐related quality of life around the time of diagnosis in patients with bladder cancer |
title_full_unstemmed | Health‐related quality of life around the time of diagnosis in patients with bladder cancer |
title_short | Health‐related quality of life around the time of diagnosis in patients with bladder cancer |
title_sort | health‐related quality of life around the time of diagnosis in patients with bladder cancer |
topic | Urological Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907410/ https://www.ncbi.nlm.nih.gov/pubmed/31077532 http://dx.doi.org/10.1111/bju.14804 |
work_keys_str_mv | AT yuevanyiwen healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer AT nekemanduncan healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer AT billinghamlucindaj healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer AT jamesnicholasd healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer AT chengkk healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer AT bryanrichardt healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer AT wesseliusanke healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer AT zeegersmauricep healthrelatedqualityoflifearoundthetimeofdiagnosisinpatientswithbladdercancer |